Penumbra Share Holder Equity 2014-2024 | PEN
Penumbra share holder equity from 2014 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- Penumbra share holder equity for the quarter ending September 30, 2024 was $1.104B, a 0.01% increase year-over-year.
- Penumbra share holder equity for 2023 was $1.179B, a 18.03% increase from 2022.
- Penumbra share holder equity for 2022 was $0.999B, a 4.71% increase from 2021.
- Penumbra share holder equity for 2021 was $0.954B, a 49.57% increase from 2020.
| Penumbra Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $1,179 |
| 2022 | $999 |
| 2021 | $954 |
| 2020 | $638 |
| 2019 | $486 |
| 2018 | $422 |
| 2017 | $400 |
| 2016 | $267 |
| 2015 | $233 |
| 2014 | $99 |
| 2013 | $48 |
| Penumbra Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,104 |
| 2024-06-30 | $1,161 |
| 2024-03-31 | $1,204 |
| 2023-12-31 | $1,179 |
| 2023-09-30 | $1,104 |
| 2023-06-30 | $1,067 |
| 2023-03-31 | $1,024 |
| 2022-12-31 | $999 |
| 2022-09-30 | $974 |
| 2022-06-30 | $970 |
| 2022-03-31 | $959 |
| 2021-12-31 | $954 |
| 2021-09-30 | $685 |
| 2021-06-30 | $673 |
| 2021-03-31 | $650 |
| 2020-12-31 | $638 |
| 2020-09-30 | $620 |
| 2020-06-30 | $623 |
| 2020-03-31 | $488 |
| 2019-12-31 | $486 |
| 2019-09-30 | $467 |
| 2019-06-30 | $454 |
| 2019-03-31 | $437 |
| 2018-12-31 | $422 |
| 2018-09-30 | $409 |
| 2018-06-30 | $425 |
| 2018-03-31 | $415 |
| 2017-12-31 | $400 |
| 2017-09-30 | $384 |
| 2017-06-30 | $373 |
| 2017-03-31 | $373 |
| 2016-12-31 | $267 |
| 2016-09-30 | $254 |
| 2016-06-30 | $248 |
| 2016-03-31 | $238 |
| 2015-12-31 | $233 |
| 2015-09-30 | $229 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.225B | $1.059B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.335B | 24.68 |
| Intuitive Surgical (ISRG) | United States | $191.275B | 100.00 |
| Edwards Lifesciences (EW) | United States | $44.459B | 28.23 |
| Alcon (ALC) | Switzerland | $42.458B | 28.41 |
| IQVIA Holdings (IQV) | United States | $36.298B | 20.00 |
| IDEXX Laboratories (IDXX) | United States | $33.869B | 39.89 |
| DexCom (DXCM) | United States | $31.341B | 47.20 |
| Waters (WAT) | United States | $22.156B | 32.76 |
| STERIS (STE) | Ireland | $20.598B | 23.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.820B | 0.00 |
| Hologic (HOLX) | United States | $16.494B | 17.81 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.327B | 13.68 |
| Sysmex ADR (SSMXY) | Japan | $11.738B | 36.81 |
| Globus Medical (GMED) | United States | $11.366B | 28.78 |
| Masimo (MASI) | United States | $9.011B | 43.60 |
| Glaukos (GKOS) | United States | $8.338B | 0.00 |
| Teleflex (TFX) | United States | $8.233B | 13.13 |
| Integer Holdings (ITGR) | United States | $4.520B | 25.62 |
| PROCEPT BioRobotics (PRCT) | United States | $4.369B | 0.00 |
| Veracyte (VCYT) | United States | $3.191B | 95.77 |
| Inari Medical (NARI) | United States | $3.141B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.539B | 14.65 |
| Tandem Diabetes Care (TNDM) | United States | $2.430B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.408B | 18.29 |
| TransMedics (TMDX) | United States | $2.145B | 67.98 |
| Elekta AB (EKTAY) | Sweden | $2.014B | 18.10 |
| Integra LifeSciences Holdings (IART) | United States | $1.708B | 8.92 |
| RxSight (RXST) | United States | $1.389B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.309B | 0.00 |
| Artivion (AORT) | United States | $1.197B | 79.31 |
| Pulse Biosciences (PLSE) | United States | $1.128B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Paragon 28 (FNA) | United States | $0.860B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.736B | 12.52 |
| AxoGen (AXGN) | United States | $0.716B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.713B | 16.81 |
| IRadimed (IRMD) | United States | $0.687B | 37.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.663B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.661B | 34.77 |
| SiBone (SIBN) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.534B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.433B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
| Delcath Systems (DCTH) | United States | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.201B | 0.00 |
| Accuray (ARAY) | United States | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Nevro (NVRO) | United States | $0.149B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.130B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 11.93 |
| LENSAR (LNSR) | United States | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.069B | 0.00 |
| 908 Devices (MASS) | United States | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Neuronetics (STIM) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |